scispace - formally typeset
G

Gisele Pereira Dias

Researcher at Federal University of Rio de Janeiro

Publications -  31
Citations -  1302

Gisele Pereira Dias is an academic researcher from Federal University of Rio de Janeiro. The author has contributed to research in topics: Panic disorder & Paroxetine. The author has an hindex of 13, co-authored 31 publications receiving 667 citations. Previous affiliations of Gisele Pereira Dias include King's College London & University of Cagliari.

Papers
More filters
Journal ArticleDOI

Translational Findings on Brain-Derived Neurotrophic Factor and Anxiety: Contributions from Basic Research to Clinical Practice

TL;DR: Developing pharmacological strategies facilitating the release of BDNF from synapses or prolongation of the half-life of secreted BDNF may improve the therapeutic responses of humans expressing the BDNF polymorphism.
Journal ArticleDOI

Effects of diet on brain plasticity in animal and human studies: mind the gap.

TL;DR: The gap in mechanistic understanding between recent findings from animal studies and those human studies reporting that these dietary factors can benefit cognition, mood, and anxiety, aging, and Alzheimer's disease is evaluated—with focus on the enhancement of structural and functional plasticity markers in the hippocampus.
Journal ArticleDOI

The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety.

TL;DR: Some recent findings addressing the effects of different dietary polyphenols on hippocampal cell proliferation and differentiation, models of anxiety, and depression as well as some proposed molecular mechanisms underlying those effects are discussed with particular focus on those related to AHN.
Journal ArticleDOI

Current findings of fMRI in panic disorder: contributions for the fear neurocircuitry and CBT effects.

TL;DR: The PD fMRI neurobiological findings are correlated with the fear neurocircuitry hypothesis; the hypothesis is linked to cognitive–behavior therapy findings; and comment on fMRI study limitations and suggest methodological changes for future research are commented on.
Journal ArticleDOI

Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms

TL;DR: The effects of cancer treatments on AHN are discussed and a link between the inhibition of the neurogenetic process in the hippocampus and the advent of the cognitive and mood-based deficits observed in patients and animal models undergoing cancer therapies is proposed.